Clearside “Sapphire” CLS1003-301

Currently Enrolling

A Phase 3, randomized, masked, controlled trial to study the Safety and Efficacy of Suprachoroidal CLS-TA in conjunctions with Intravitreal Aflibercept in patients with Retinal Vein Occlusion

Duration: 48 weeks

 

This entry was posted in Uncategorized. Bookmark the permalink.